Skip to main content

and
Your search also matched 7 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent

Include preview-only content
  1. Article

    Open Access

    Treatment of Complex Femoro-popliteal Lesions: Time to Revise the Guidelines According to Clinical Reality

    Thomas Zeller in CardioVascular and Interventional Radiology (2023)

  2. Article

    Open Access

    Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis

    To summarize the 5-year outcomes of drug-coated balloon (DCB) for the treatment of femoropopliteal lesions in patients with diabetes mellitus (DM) or chronic limb-threatening ischemia (CLTI) compared to non-DM...

    Michel M. P. J. Reijnen, Iris van Wijck in CardioVascular and Interventional Radiology (2023)

  3. Article

    Open Access

    Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial

    This study aimed to assess 5-year effectiveness and safety of femoropopliteal angioplasty with the Luminor® 35 drug-coated balloon (DCB).

    Ulf Teichgräber, Thomas Lehmann in CardioVascular and Interventional Radiology (2022)

  4. Article

    Open Access

    Sirolimus-Coated Balloon Angioplasty of Infra-popliteal Lesions for the Treatment of Chronic Limb-Threatening Ischemia: Study Protocol for the Randomized Controlled LIMES Study

    Evidence on efficacy and long-term safety of paclitaxel-coated devices is still conflicting. Therefore, this study aims to assess whether sirolimus-coated balloon angioplasty is safe and effective for the trea...

    Ulf Teichgräber, Stephanie Platzer in CardioVascular and Interventional Radiology (2022)

  5. Article

    Open Access

    Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study

    Data on the long-term safety and effectiveness of drug-coated balloons (DCBs) for the treatment of long femoropopliteal atherosclerotic lesions in the real-world setting are rare. This study reports 3 year and...

    Marianne Brodmann, Wouter Lansink in CardioVascular and Interventional Radiology (2022)

  6. Article

    Open Access

    Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis

    To evaluate the use of drug-coated balloons in a real-world patient population with peripheral arterial disease and analyse the impact of sex on mid-term outcomes following their utilisation.

    Ian Patrick Barry, Reane Macarulay in CardioVascular and Interventional Radiology (2022)

  7. Article

    Open Access

    Time for a Standardized Common Femoral Artery Classification System

    Thomas Zeller in CardioVascular and Interventional Radiology (2022)

  8. Article

    Open Access

    Correction to: Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry

    A correction to this paper has been published: https://doi.org/10.1007/s00270-021-02862-w

    Gunnar Tepe, Thomas Zeller, Matej Moscovic in CardioVascular and Interventional Radiology (2021)

  9. Article

    Open Access

    Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent

    Develop a prediction model to determine the impact of patient and lesion factors on freedom from target lesion revascularization (ffTLR) for patients who are candidates for Zilver PTX drug-eluting stent (DES) ...

    Michael D. Dake, Fabrizio Fanelli in CardioVascular and Interventional Radiology (2021)

  10. Article

    Open Access

    Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry

    After promising small randomized trials, the aim of BIOLUX P-III was to further investigate the safety and performance of the Passeo-18 lx drug-coated balloon in infrainguinal arteries under real-world conditi...

    Gunnar Tepe, Thomas Zeller, Matej Moscovic in CardioVascular and Interventional Radiology (2021)

  11. Article

    Open Access

    Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices

    Patient-level data from two large studies of the Zilver PTX drug-eluting stent (DES) with long-term follow-up and concurrent non-drug comparator groups were analyzed to determine whether there was an increased...

    Michael D. Dake, Gary M. Ansel, Marc Bosiers in CardioVascular and Interventional Radiology (2020)

  12. Article

    Correction to: Impact of Patient and Lesion Characteristics on Drug-Coated Balloon Angioplasty in the Femoropopliteal Artery: A Pooled Analysis of Four Randomized Controlled Multicenter Trials

    In their recently published pooled analysis of four drug-coated balloon (DCB) studies, which focused on the impact of patient and lesion characteristics on LLL at 6 months (Albrecht T et al. Cardiovasc Interve...

    Thomas Albrecht, Antonia Ukrow, Michael Werk in CardioVascular and Interventional Radiology (2019)

  13. Article

    Erratum to: Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial

    Johannes Lammer, Thomas Zeller in CardioVascular and Interventional Radiology (2015)

  14. Article

    AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis

    Marc Bosiers, Patrick Peeters in CardioVascular and Interventional Radiology (2009)